Clinical ink announc
Clinical ink announces GlucoseReady™
23 avr. 2024 08h00 HE | Clinical Ink
Winston Salem, NC, April 23, 2024 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, today announced the launch of GlucoseReady™, a fully integrated GCP compliant digital...
Global Electronic Clinical Outcome Assessment (eCOA) Solution Market
Global Electronic Clinical Outcome Assessment Solution Market Analysis Report 2024-2029: Surging Adoption Owing to Increasing Number of Clinical Trials in Emerging Economies
18 mars 2024 07h10 HE | Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Electronic Clinical Outcome Assessment (eCOA) Solution Market by Modality (Wearable, Mobile, BYOD), Type (PRO, CLINRO, OBSRO, PERFO), Use...
MnM_logo_TM_JPG.JPG
Electronic Clinical Outcome Assessment (eCOA) Solution Market is Expected to Reach $3.9 Billion | MarketsandMarkets™
08 mars 2024 07h30 HE | MarketsandMarkets Research Pvt. Ltd.
Chicago, March 08, 2024 (GLOBE NEWSWIRE) -- Electronic Clinical Outcome Assessment (eCOA) Solution market in terms of revenue was estimated to be worth $1.8 billion in 2024 and is poised to reach...
Y-Prime_Logo_rgb_color.png
YPrime's Latest Research Reveals Significant Impact of eCOA Platform Delays on Clinical Trial Efficiency
30 janv. 2024 08h00 HE | Y-Prime, LLC
YPrime eCOA research reveals stakeholders' concerns about timelines and data quality.
22157.jpg
eCOA and ePRO Market Outlook to 2031: The Future Backbone of An Interconnected and Agile Healthcare Ecosystem
25 janv. 2024 11h45 HE | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "ePRO, E-patient Diaries and eCOA Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
YPrime Brand Launch Image
YPrime Unveils a Transformative Brand Focused on Solving for Certainty in Clinical Trials
22 janv. 2024 07h45 HE | Y-Prime, LLC
YPrime announces bold rebranding and re-commitment to provide cutting-edge technologies to streamline and accelerate clinical trials.
Clinical ink Expands
Clinical ink Expands Patient Engagement Solutions with Behavioral Diagnostic Tool SPUR™
13 nov. 2023 14h13 HE | Clinical Ink
Winston Salem, NC, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, is expanding its patient engagement suite with the inclusion of the SPUR behavioral...
Clinical ink Introdu
Clinical ink Introduces Breakthrough Solution to Drastically Reduce Study Build Timelines
12 oct. 2023 06h00 HE | Clinical Ink
Winston Salem, NC, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, is setting a new industry benchmark in advancing study build timelines. Harnessing the...
Vantage Market Research.png
eClinical Solution Software Market Size & Share to Surpass $210 Billion by 2030 | Vantage Market Research
20 juil. 2023 06h41 HE | Vantage Market Research
WASHINGTON, July 20, 2023 (GLOBE NEWSWIRE) -- The E-clinical Solution Software Market is valued at USD 33.3 Billion in 2022 and is expected to reach USD 210 Billion by 2030 at a CAGR of 30.1% over...
Axiom-22 Anniversary Logo - Transparent.png
Axiom Showcasing Fusion eClinical Suite - BIO International 2023
01 juin 2023 13h28 HE | Axiom Real-Time Metrics Inc
TORONTO, June 01, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), the premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...